evolocumab
Beyond statins, one drug lowered heart attack risk by 20%
Beyond statins, one drug lowered heart attack risk by 20%
Evolocumab, sold under the brand name Repatha, is a monoclonal antibody drug. It is an immunotherapy medication for the treatment of hyperlipidemia.
From Wikipedia ↗, the free encyclopedia. Text available under CC BY-SA 4.0.
evolocumab was first seen on Google Trends · United Kingdom on Nov 6, 2026. Since then it has appeared in 1 check on 1 different day. Its best position was #1 of 10, reached on Nov 6, 07:36 UTC. It dropped off the list after Nov 6, 07:36 UTC.
Position on Google Trends · United Kingdom at every check (lower is better).
Best rank per day (UTC).
Archived daily, weekly and monthly lists that include this entry.
Not at the moment. It was last on the list on Nov 6, 07:36 UTC, after 1 day of trending.
#1 on Google Trends · United Kingdom, on Nov 6, 07:36 UTC. Trendoday checks this list every 60 minutes.
It was first seen on Nov 6, 2026 and has been on the list on 1 day (1 check) since.
According to Wikipedia: Pharmaceutical drug.